Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

INOVIQ Ltd

IIQ.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia Micro Cap Analyst: N/A

Last Close

$0.14

▲ +2.63%

Market Cap $19.36M · Vol 31.42K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$19.36M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

46.67

Momentum

Beta

1.84

vs Market

52W High

$0.40

64.65% below

52W Low

$0.13

7.33% above

Volume

31.42K

Avg 187.30K

P/B

2.47

Price-to-book

ROE

82.00%

Return on equity

Free Float

66.05%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, INOVIQ Ltd (IIQ.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does IIQ.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.88%

-13.33%

-39.06%

-40.91%

YTD

-49.68%

-55.17%

-68.99%

-86.87%

Financials & Valuation

TTM · Annual

Total Revenue	$631.23K
Net Income	$-4,561,431.00
Revenue Growth (YoY)	-9.71%
Gross Margin	-30.25%
Operating Margin	-852.51%
Net Profit Margin	-722.63%
ROE	82.00%
ROA · ROIC	-34.52% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	42.89
P/B	2.47
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	140.78M

Technical Indicators

50-Day SMA	$0.20
200-Day SMA	$0.23
RSI (14)	46.67
Beta	1.84
52-Week High	$0.40
52-Week Low	$0.13

Volume Today	31.42K
Avg Daily Volume (30D)	187.30K
Relative Volume	0.17x
Volatility (10D)	47.38
Volatility (30D)	78.51
Free Float	66.05%

Analyst Consensus

N/A

Current Price $0.14

Mean Target N/A

52W Low$0.13 52W High$0.40

Current

Target

$0.13 $0.40

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001S5Y1G8

ISINAU0000196149

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

INOVIQ Ltd is an Australia-based biotechnology company developing diagnostics and therapeutics for cancer. The Company's commercialized products include EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The Company is also advancing clinical-stage diagnostics for the detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumors.